| 注册
首页|期刊导航|临床肝胆病杂志|传统非侵入性纤维化模型对慢性乙型肝炎合并代谢相关脂肪性肝病发生显著肝纤维化的诊断价值

传统非侵入性纤维化模型对慢性乙型肝炎合并代谢相关脂肪性肝病发生显著肝纤维化的诊断价值

黄柏盛 区蓝芯 张莹洁 施梅姐 黎胜 萧焕明 池晓玲

临床肝胆病杂志2023,Vol.39Issue(9):2110-2116,7.
临床肝胆病杂志2023,Vol.39Issue(9):2110-2116,7.DOI:10.3969/j.issn.1001-5256.2023.09.012

传统非侵入性纤维化模型对慢性乙型肝炎合并代谢相关脂肪性肝病发生显著肝纤维化的诊断价值

Value of traditional noninvasive fibrosis models in diagnosis of significant liver fibrosis in patients with chronic hepatitis B and metabolic associated fatty liver disease

黄柏盛 1区蓝芯 1张莹洁 1施梅姐 2黎胜 2萧焕明 2池晓玲2

作者信息

  • 1. 广州中医药大学第二临床医学院, 广州 510006
  • 2. 广州中医药大学第二附属医院肝病科, 广州 510120||广东省中医院肝病科, 广州 510120
  • 折叠

摘要

关键词

乙型肝炎,慢性/非酒精性脂肪性肝病/肝纤维化/诊断

Key words

Hepatitis B,Chronic/Non-alcoholic Fatty Liver Disease/Hepatic Fibrosis/Diagnosis

引用本文复制引用

黄柏盛,区蓝芯,张莹洁,施梅姐,黎胜,萧焕明,池晓玲..传统非侵入性纤维化模型对慢性乙型肝炎合并代谢相关脂肪性肝病发生显著肝纤维化的诊断价值[J].临床肝胆病杂志,2023,39(9):2110-2116,7.

基金项目

国家"十三五"重大传染病专项课题(2018ZX10725506-003,2018ZX10725505-004) (2018ZX10725506-003,2018ZX10725505-004)

广东省中医院院内专项(YN10101903,YN2016XP03) (YN10101903,YN2016XP03)

省部共建中医湿证国家实验室开放课题(SZ2022KF02) (SZ2022KF02)

池晓玲国家中医药管理局名老中医药专家传承工作室项目(国中医药人教函[2022]75号) (国中医药人教函[2022]75号)

第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号) The Thirteenth Five-Year Plan for Major and Special Programs of the National Science and Technology of China(2018ZX10725506-003,2018ZX10725505-004) (国中医药人教函[2022]1号)

The Science and Technology Research Project of Traditional Chinese Medicine of Guangdong Provincial Hospital of Chinese Medicine(YN10101903,YN2016XP03) (YN10101903,YN2016XP03)

Open Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine(SZ2022KF02) (SZ2022KF02)

Chi Xiaoling of Project of Inheritance Workshop of Famous Old Chinese Medicine Experts of State Administration of Traditional Chinese Medicine(Guozhong Pharmaceutical Human Education Letter[2022]No.75) (Guozhong Pharmaceutical Human Education Letter[2022]No.75)

The Fifth Batch of National Research and Training Programs for Clinical Talents of Traditional Chinese Medicine(Guozhong Pharmaceutical Human Education Letter[2022]No.1) (Guozhong Pharmaceutical Human Education Letter[2022]No.1)

临床肝胆病杂志

OACSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文